Switching biologics for CRSwNP is frequent in Canadian rhinology; the most common switch is from mepolizumab to dupilumab, with inadequate CRSwNP control driving the switch.
Steroid-Eluting Stents May Not Add Post-Operative Benefit Over Irrigation in Patients with Chronic Sinusitis with Nasal Polyps
For chronic rhinosinusitis with nasal polyps (CRSwNP), with or without asthma, without other underlying systemic disease factors, steroid-eluting stents may not add benefit over steroid rinses.
Biologics Shown Effective in Real-World Setting for Managing Patients with Severe Chronic Rhinosinusitis with Nasal Polyps
How do the clinical effects and response times of dupilumab, omalizumab, and mepolizumab compare when treating patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP)?
Canadian Rhinologists More Comfortable with Prescribing and Managing Biologics for CRSwNP than Non-Rhinologists
What can be learned from otolaryngologists’ experiences in prescribing biologics for patients with chronic rhinosinusitis with nasal polyposis (CRSwNP), including prescribing practices, patient factors guiding prescriber decisions, and physician
Biologics For Chronic Rhinosinusitis: How And When To Use Them For The Best Response
Biologics represent a breakthrough for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). But with high non-response rates and other unresolved issues, researchers are exploring how best to put these therapies to work, panelists said in a session at the Triological Society Combined Sections Meeting.
Low-Dose Macrolides Can Help Patients with Chronic Rhinosinusitis
LDMs provided favorable outcomes in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Do Preoperative Corticosteroids Benefit Patients with Chronic Rhinosinusitis with Nasal Polyposis?
Multiple therapeutic options may be effective for treating mild pediatric OSA including observation, management with anti-inflammatory medications, and surgery.
Sinus Surgery Improves Olfaction for About Half of Patients with CRS
Olfaction can be improved by sinus surgery in about every second chronic rhinosinusitis (CRS) patient.
Is Aspirin Desensitization Indicated for Treatment of Recalcitrant CRSwNP in AERD?
Desensitization is cost-effective, with several high-quality studies demonstrating improved disease control